BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220209
DTEND;VALUE=DATE:20220211
DTSTAMP:20260516T003125
CREATED:20211013T105724Z
LAST-MODIFIED:20220114T094327Z
UID:31828-1644364800-1644537599@www.pharmajournalist.com
SUMMARY:SMi’s 13th Annual RNA Therapeutics Conference
DESCRIPTION:SMi Group’s 13th Annual Conference: \nRNA Therapeutics 2022\n9th – 10th February 2022\nVirtual Conference: Online Access Only\nwww.therapeutics-rna.com \nSponsored by: BIA Separations | eTheRNA Immunotherapies | Thermo Fisher Scientific \nBolstering the latest advances and opportunities in RNA-based medicine \nThe RNA therapeutics industry has grown at an exponential rate in recent years\, with an increased spotlight following the industry’s leading role in developing vaccines against COVID-19 in response to the global pandemic. This year’s conference will reflect on how the industry has adapted and played a pivotal role in global health over the past year and will discuss the takeaways for future mRNA therapeutic development. \nThe 2022 agenda will explore innovations in novel and targeted delivery\, RNAi innovations and antisense oligonucleotide therapeutics. Global experts from big pharma and leading biotechs will explore the emerging therapeutic applications of RNA with case studies on the treatment of cardiovascular disease\, neurological diseases\, and oncology.
URL:https://www.pharmajournalist.com/event/smis-13th-annual-rna-therapeutics-conference/
LOCATION:Virtual Conference: Online Access Only
ORGANIZER;CN="SMi Group Ltd":MAILTO:ngaloria@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220209
DTEND;VALUE=DATE:20220211
DTSTAMP:20260516T003125
CREATED:20211210T000811Z
LAST-MODIFIED:20220117T123916Z
UID:32418-1644364800-1644537599@www.pharmajournalist.com
SUMMARY:SMi’s 5th Annual 3D Cell Culture Conference
DESCRIPTION:SMi’s 5th Annual 3D Cell Culture Conference \nVirtual Conference: Online Access Only \n9-10 February 2022 \nhttp://www.3d-cellculture.com/ \nSponsored by: CELLINK\, CelVivo\, Promega and Newcells BiotechDeveloping Complex\, Translatable and Physiologically-Relevant Cellular Models in vitro \nConference Co-Chairs: Stefan Przyborski\, Professor of Cell Technology\, Durham University and Philip Hewitt\, Global Head of Early Investigative Toxicology\, Merck \n3D Cell Culture is gaining momentum in the pharmaceutical industry on account of the advantages such models pose for in drug discovery\, from improved clinical translation and predictivity\, to patient safety and sustainability. \nSMi’s 3D Cell Culture Conference will explore advances in the application of 3D cell models\, from their employment in drug screening to reduce candidate attrition\, to the latest insights into microphysiological systems\, the regulatory landscape\, and the clinical applications of 3D bioprinting. \nEvent Hashtag: #SMi3DCellCulture \nKey Benefits of Attending: \n\nDiscuss the uses of advanced cell technologies to construct in vitro models of human tissues\nExplore the regulatory sciences surrounding Microphysiological systems\, and their development and adoption for drug safety assessment\nUncover the major benefits of 3D modelling in enhancing clinical translation and predictability\nUtilise 3D cell culture for High Throughput drug discovery and Content screening over traditional 2D methods\n\n\n• Delve into advanced case studies looking into organ models: from organotypic lungs to liver spheroids\n\n WHO SHOULD ATTEND? \nBiotech / Pharma Companies – Team Leader\, Junior Principle investigator\, Cell and Molecular Scientist\, Chief Scientific Officer\, Deputy Director\, Manager\, Founder\, CEO\, Head\, Director\, Programme Manager\, Lab Head\, Toxicologist \nAcademia Professor – Cell Technology\, Stem Cell Sciences\, Biochemistry\, Protein Technology and Tissue Engineering \nSolution Providers – Manager\, Head of\, CEO\, Director\, Founder\, Account Manager\, President\, CSO\, Executive\, Managing Director\, Vice President\, COO \nOrganisations / Regulatory – Director\, Senior Science Advisor\, Scientific Officer
URL:https://www.pharmajournalist.com/event/smis-5th-annual-3d-cell-culture-conference-2022/
LOCATION:Virtual Conference: Online Access Only
ORGANIZER;CN="SMi Events":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
END:VCALENDAR